BOK Financial Private Wealth Inc. Has $1.67 Million Position in Zoetis Inc. (NYSE:ZTS)

BOK Financial Private Wealth Inc. trimmed its stake in Zoetis Inc. (NYSE:ZTS) by 8.1% in the fourth quarter, HoldingsChannel reports. The firm owned 10,274 shares of the company’s stock after selling 908 shares during the period. BOK Financial Private Wealth Inc.’s holdings in Zoetis were worth $1,674,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Mizuho Securities USA LLC grew its stake in shares of Zoetis by 13,726.9% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company’s stock valued at $950,524,000 after buying an additional 4,829,815 shares during the period. Raymond James Financial Inc. acquired a new position in Zoetis during the 4th quarter worth approximately $196,651,000. Amundi boosted its holdings in Zoetis by 46.2% in the fourth quarter. Amundi now owns 2,748,719 shares of the company’s stock worth $453,355,000 after acquiring an additional 867,993 shares in the last quarter. Assenagon Asset Management S.A. grew its stake in Zoetis by 296.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 889,444 shares of the company’s stock valued at $144,917,000 after acquiring an additional 665,331 shares during the period. Finally, Nordea Investment Management AB increased its holdings in shares of Zoetis by 38.3% during the fourth quarter. Nordea Investment Management AB now owns 2,065,514 shares of the company’s stock valued at $336,266,000 after acquiring an additional 572,511 shares in the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on ZTS shares. Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Stifel Nicolaus reduced their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. UBS Group started coverage on shares of Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 target price on the stock. StockNews.com raised shares of Zoetis from a “hold” rating to a “buy” rating in a research report on Friday. Finally, Piper Sandler boosted their price objective on Zoetis from $200.00 to $205.00 and gave the stock an “overweight” rating in a report on Thursday, February 27th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $215.90.

Zoetis Trading Up 1.8 %

Shares of Zoetis stock opened at $170.34 on Friday. The stock has a fifty day simple moving average of $166.72 and a 200 day simple moving average of $176.78. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $200.33. The company has a market capitalization of $76.28 billion, a P/E ratio of 31.14, a price-to-earnings-growth ratio of 2.78 and a beta of 0.94. The company has a current ratio of 1.75, a quick ratio of 1.08 and a debt-to-equity ratio of 1.09.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.03. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The business had revenue of $2.32 billion for the quarter, compared to analysts’ expectations of $2.30 billion. On average, sell-side analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be given a dividend of $0.50 per share. The ex-dividend date is Monday, April 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.17%. Zoetis’s dividend payout ratio is presently 36.56%.

Insider Activity

In related news, EVP Roxanne Lagano sold 326 shares of the business’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $171.18, for a total transaction of $55,804.68. Following the sale, the executive vice president now directly owns 16,107 shares in the company, valued at approximately $2,757,196.26. The trade was a 1.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.16% of the company’s stock.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.